It is never dull when activist investors take an interest in a high-profile company. For Entain PLC (LSE:ENT), this week's comments from Sachem Head Capital Management have again stirred the pot.
HANOVER, Md. , Oct. 23, 2025 /PRNewswire/ -- Allegis Global Solutions, the leading provider of global workforce solutions, has been named a UiPath AI25 Award winner.
Calgary, Alberta--(Newsfile Corp. - October 23, 2025) - Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) ("Fathom", or the "Company") is pleased to announce an updated geology map reflecting the most recent prospecting and pXRF (Portable X-ray Florescence) rock geochemistry results at the Gochager Lake project. The historic Gochager Lake deposit host rock (the "container rock"), has now been mapped consistently along strike northeast of the historic Gochager Lake deposit for a minimum distance of 3.5 kilometers.
Enabled by deep industry verticalized teams and accelerators combined with integrated services and agentic capabilities — driving enterprise-wide AI adoption at scale NEWTOWN, Pa. , Oct. 23, 2025 /PRNewswire/ -- EPAM Systems, Inc. (NYSE: EPAM) today announced the launch of AI/Run™.Transform Playbook — the next-generation of integrated consulting services built with AI to boost enterprise-wide AI-native transformation.
Rimouski, Québec--(Newsfile Corp. - October 23, 2025) - Puma Exploration Inc. (TSXV: PUMA) (OTCQB: PUMXF) (the "Company" or "Puma") is pleased to announce results from its 2025 channel sampling program at the Lynx Gold Zone ("LGZ") at its Williams Brook Gold Project in Northern New Brunswick. The program revealed multiple high-grade gold intervals, including 68.90 g/t Au over 0.50 m, 54.40 g/t Au over 0.90 m, 53.00 g/t Au over 0.60 m, 48.00 g/t Au over 0.50 m and 34.50 g/t Au over 0.50 m (Figure 1).
AutoNation recorded higher third-quarter profit and sales as the company saw growth across all of its major categories, including new vehicles.
Eli Lilly is a Strong Buy, driven by exceptional growth in obesity and diabetes drugs Mounjaro and Zepbound, plus pipeline innovation. LLY's diversified business mix, global reach, and proactive U.S. manufacturing investments position it well for regulatory and political developments. Despite sector headwinds and cautious market sentiment, LLY's robust earnings momentum and positive analyst revisions support continued outperformance.
American Airlines lost money in every region in the third quarter but projected a current quarter profit.
Atlantic Health, a leading provider of health care based in New Jersey, to conduct the investigator-initiated Phase 1B/2 study Preclinical studies indicate Annamycin targets key factors in pancreatic cancer HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viral infections, today announced it is working with Atlantic Health on an investigator-initiated Phase 1B/2 single-arm study evaluating Annamycin for third-line ("3L") treatment of advanced pancreatic cancer. Pancreatic cancer continues to present significant treatment challenges, being the cancer with the highest mortality rate globally and the seventh leading cause of cancer death.
PRINCETON, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for I.V.
OAKLAND, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB: LOGC), (“ContextLogic” or the “Company”) today announced it will report its third quarter 2025 financial results after the close of market on Tuesday, October 28, 2025.
CLEARWATER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that financial results for the third quarter of fiscal year 2025 will be released before markets open on Thursday, November 6th.
Vancouver, British Columbia, and Sacramento, California--(Newsfile Corp. - October 23, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the release of a new video interview with the Company's CEO in partnership with Departures Capital. The interview delves into the Company's story and near-term execution plan around its flagship device, IzoView, a dedicated breast CT platform.
Vancouver, British Columbia – TheNewswire - October 23, 2025 – Pangea Natural Foods Inc. (CSE: PNGA) (OTC: PNGAF) (“ Pangea ” or the “ Company ”), is pleased to announce that its wholly owned subsidiary, Amino Innovations, has formed a strategic scientific collaboration partnership with two world-renowned pharmaceutical scientists, Dr. Neal Davies and Dr. Raimar Loebenberg, to accelerate the research, validation, and development of advanced non-injectable peptide delivery systems for consumer wellness applications. Dr. Davies and Dr. Loebenberg, both senior professors in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, will provide formulation and validation expertise through a Research Services Agreement that leverages access to the University's Drug Development and Innovation Centre (DDIC) and its state-of-the-art facilities, personnel, and pharmaceutical testing platforms.
MCDONALD, Tenn., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value C103, refractory alloy, and titanium powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, is pleased to provide an overview of its operations to accompany the Appendix 4C for the quarterly period ending 30 September 2025 (“Quarter”, “Reporting Period”).
BENTONVILLE, Ark., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) is pleased to announce the appointment of Edmund (Ned) Burke, a highly accomplished financial services executive, to its Board of Directors. With more than four decades of leadership experience at prominent investment firms including Pioneer Funds and Fidelity Investments, Mr. Burke brings exceptional financial acumen and strategic insight to the company's leadership team.
Vancouver, British Columbia--(Newsfile Corp. - October 23, 2025) - Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT), is pleased to announce that it will present at Red Cloud's Fall Mining Showcase 2025.
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced presentation of a poster entitled “Targeting HPV E6/E7 Upregulation of the Transmembrane Receptor Tyrosine Kinase ROR2 with the ADC Ozuriftamab Vedotin in Patients with Advanced HPV+ Oropharyngeal Squamous Cell Carcinoma” which details clinical data from its investigational antibody-drug conjugate (ADC), ozuriftamab vedotin (Oz-V), at the International Papillomavirus Society (IPVS) Conference, taking place October 23–26, 2025, in Bangkok, Thailand.
Beta launch introduces deterministic CTV measurement to global markets, connecting premium streaming exposure to qualified visits, leads, and sales Beta launch introduces deterministic CTV measurement to global markets, connecting premium streaming exposure to qualified visits, leads, and sales
SHERIDAN, Wyo. , Oct. 23, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") Ramaco is proud to announce that initial mobilization and site development activities have commenced for its new pilot processing plant and laboratory, located adjacent to the Brook Mine and near the iCAM Research Center outside Sheridan, Wyoming.